The impact of lymphadenectomy on the survival of patients with stage I ovarian clear cell carcinoma.

Tingting Li, Chunyan Tan, Sixia Xie, Hongjing Wang

Abstract read

In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tingting Li *Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Chunyan Tan *Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Sixia Xie *Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Hongjing WangDepartment of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the impact of lymphadenectomy on the survival of patients with stage I ovarian clear cell carcinoma (OCCC). Methods: The records of 93 patients with stage I OCCC treated between January 2012 and December 2019 were reviewed retrospectively. The relationships between survival outcomes and the number and region of removed lymph nodes (LNs) were assessed, and the independent prognostic factors were analyzed. Results: The median number of LNs resected in 93 patients was 24. These patients were divided into two groups based on the median number; overall survival (OS) and recurrence-free survival (RFS) differed significantly between the two groups. Patients were also grouped by the region of the LNs: the pelvic lymph node dissection (PLND) and PLND and para-aortic. Moreover, no differences in OS or RFS were observed between the two groups. Cox regression analysis demonstrated that the number of removed LNs was a significant and independent prognostic factor for poor RFS. Conclusion: This study exhibited that the number of removed LNs, as an important measure of adequate lymphadenectomy for stage I OCCC, contributed to improved RFS and OS. An independent prognostic factor for stage I OCCC was the number of dissected LNs.

Indexed as

lymphadenectomyovarian clear cell carcinomaprognosissurvivalthe number of lymph nodes

Identifiers

PMID39610934

DOI10.3389/fonc.2024.1425214

PMCPMC11602395

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.